glp-1 therapies success rates Long-term of GLP-1s Hinges on More Than Just a Prescription GLP-1 therapies and mortality risk:

Long-acting agents (semaglutide weekly, dulaglutide, tirzepatide) produce continuous but physiologically attenuated gastric slowing because of tachyphylaxis at the gastric GLP-1 receptor [3]

PMID: 36960397

Manipulation of gut microbiota influences immune responses, axon preservation, and motor disability in a model of progressive multiple sclerosis

Here is something that might surprise you, and that I haven't seen any other dental blog mention

Our healthcare team will work with you to identify these conditions and develop personalized treatment planswhether that involves lifestyle changes, medication, or other interventionsto help you achieve your best possible health outcomes